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ABSTRACT
Introduction: The biological diversity of circulating Trypanosoma cruzi stocks in the Amazon 
region most likely plays an important role in the peculiar clinic-epidemiological features of 
Chagas disease in this area. Methods: Seven stocks of T. cruzi were recently isolated in the 
State of Amazonas, Brazil, from humans, wild mammals, and triatomines. They belonged to the 
TcI and Z3 genotypes and were biologically characterized in Swiss mice. Parasitological and 
histopathological parameters were determined. Results: Four stocks did not promote patent 
parasitemia in mice. Three stocks produced low parasitemia, long pre-patent periods, and a 
patent period of 1 day or oscillating parasitemia. Maximum parasitemia ranged from 1,400 to 
2,800 trypomastigotes/0.1mL blood. Mice inoculated with the T. cruzi stocks studied showed 
low positivity during fresh blood examinations, ranging from 0% to 28.6%. In hemoculture, 
positivity ranged from 0% to 100%. Heart tissue parasitism was observed in mice inoculated 
with stocks AM49 and AM61. Stock AM49 triggered a moderate inflammatory process in 
heart tissue. A mild inflammatory process was observed in heart tissue for stocks AM28, 
AM38, AM61, and AM69. An inflammatory process was frequently observed in skeletal 
muscle. Examinations of brain tissue revealed inflammatory foci and gliosis in mice inoculated 
with stock AM49. Conclusions: Biological and histopathological characterization allowed 
us to demonstrate the low infectivity and virulence of T. cruzi stocks isolated from the State 
of Amazonas.
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RESUMO
Introdução: A diversidade biológica dos estoques Trypanosoma cruzi circulantes na Região 
Amazônica pode desempenhar importante papel nas características clínico-epidemiológicas 
peculiares da doença de Chagas nesta área. Métodos: Sete isolados de T. cruzi do Estado do 
Amazonas provenientes de humanos, mamíferos silvestres e triatomíneos, pertencentes aos 
genótipos TcI e Z3, foram biologicamente caracterizados em camundongos Swiss. Foram 
avaliados parâmetros parasitológicos e histopatológicos. Resultados: Quatro isolados 
não produziram parasitemia patente em camundongos. Três isolados promoveram baixa 
parasitemia com longos períodos pré-patentes, período patente de um dia ou parasitemia 
oscilante. A parasitemia máxima variou de 1.400 a 2.800 tripomastigotas/0,1mL de sangue. Os 
camundongos inoculados com os isolados estudados mostraram baixa positividade no exame a 
fresco, variando de 0 a 28,6%. Para a hemocultura, a positividade variou de 0 a 100%. Parasitismo 
cardíaco foi observado em camundongos inoculados com os isolados AM49 e AM61. O isolado 
AM49 produziu inflamação moderada no tecido cardíaco. Processo inflamatório discreto foi 
observado no tecido cardíaco de camundongos inoculados com os isolados AM28, AM38, 
AM61 e AM69. Processo inflamatório em músculo esquelético foi muito frequente. O exame 
do tecido cerebral revelou focos inflamatórios e gliose em camundongos inoculados com o 
isolado AM49. Conclusões: A caracterização biológica e histopatológica demonstrou baixa 
infecciosidade e virulência dos estoques de T. cruzi isolados no Estado do Amazonas.
Palavras-chaves: Doença de Chagas. Trypanosoma cruzi. Virulência. Patogenicidade. 
Camundongos Swiss. Amazônia.
Chagas disease is an important parasitic disease 
that results from an infection by the flagellate 
protozoan Trypanosoma cruzi. Its evolutionary 
pattern is not fully defined because the factors 
that determine its considerable spatial variation in 
morbidity and mortality are unknown1. However, 
the idea that parasite variability and host response 
play important roles during the course of infection 
is consensual2. In fact, studies show that T. cruzi 
comprises a highly heterogeneous population of 
organisms, both in terms of genetic and phenotypic 
points of view, including biological (behavior in 
vertebrates and triatomines), pathological (tissue 
tropism, virulence, intensity of inflammatory 
reactions, and mortality), clinical (indeterminate 
and cardiac and/or digestive forms), immunological, 
and biochemical features2,3.
In the Amazon region, Chagas disease has 
been recognized as an important emerging 
anthropozoonosis. Information from the Brazilian 
Ministry of Health4 indicates the occurrence of 756 
cases of acute illness in the country during 2005–
2010. Most strikingly, 688 (91%) cases occurred in the 
states belonging to the Amazon region. The Brazilian 
states with the largest number of these cases were 
Pará (573 cases; 75.8%) and Amapá and Amazonas 
(54 cases each; 7.1%), which are all located in the 
Amazon region. In the State of Amazonas, Chagas 
disease has a lower morbidity and mortality than 
in the classic endemic areas, and appears mainly in 
the chronic latent form1,5. Cross-sectional studies 
in several riverine communities and piassava fiber 
collectors in the Rio Negro micro-region proved the 
high prevalence of chagasic infection in this area and 
demonstrated its low morbidity profile in the chronic 
phase of the disease6,7.
The characterization of the biological diversity 
of T. cruzi stocks circulating in the Amazon region 
is essential to understand the emergence, expansion, 
and peculiar clinic-epidemiological characteristics 
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TABLE 1 - Host, municipality of origin, method of isolation, and genetic lineage of the Trypanosoma cruzi 
stocks from the State of Amazonas, Brazil.
  Municipality Method Lineage
Trypanosoma cruzi stock Host of origin of isolation *
AM28 Didelphis  Manaus hemoculture TcI
 marsupialis   
AM38 Philander opossum Coari hemoculture TcI
AM41 Rhodnius robustus Maraã xenoculture TcI
AM49 human** Coari CSF culture TcI
AM61 Rhodnius pictipes Apuí inoculation in mice TcI
AM69 human** Santa Isabel do Rio Negro hemoculture Z3
AM70 human** Coari hemoculture Z3
CSF: cerebrospinal fluid. *molecular characterization performed by PCR of the non-transcribed spacer of the mini-
exon gene according to Fernandes et al; **patient in acute phase.
of Chagas disease in this area. Thus, the purpose of this preliminary 
study was to investigate the behavior in mice of T. cruzi stocks from 
the State of Amazonas, in the Western Brazilian Amazon.
Isolation of parasites 
The 7 sample T. cruzi stocks were obtained by the Tropical 
Medicine Foundation of Amazonas, between April 2006 and January 
2010, from 6 municipalities in the State of Amazonas. Table 1 shows 
the host, method of isolation, site of origin, and genetic lineage of 
the 7 T. cruzi stocks studied. 
For parasite isolation and culturing, heparinized blood samples 
from chagasic patients in the acute phase were inoculated into tubes 
containing a biphasic medium consisting of Novy-McNeal-Nicolle 
medium, covered with an overlay of liver-infusion tryptose medium 
containing 10% fetal calf serum and 140 mg/mL gentamyicin sulfate8. 
Approximately 0.5mL of whole blood was placed in each tube (3-5 
tubes for each person). Cultures were kept at 28°C and monitored 
microscopically for parasite growth twice a week for 2 months. One 
T. cruzi stock was isolated from a cerebrospinal fluid culture of a 
patient (a resident of the municipality of Coari (AM49)) who died 
due to acute chagasic meningoencephalitis, by the same method 
used for blood culture.
Two T. cruzi stocks were isolated from marsupials captured 
in Tomahawk traps with fruit as bait. Parasite isolation from wild 
mammals was carried out using the same technique as for human 
blood culture.
To obtain the 2 T. cruzi stocks from triatomine bugs, specimens 
were collected from palm trees in the peridomestic environment. 
Triatomines were dissected, their intestinal contents were examined 
by phase microscopy, and positive samples for trypanosomes were 
inoculated in mice for subsequent isolation by blood culture.
After isolation, the stocks were immediately cryopreserved in 
liquid nitrogen (-193°C) in the trypanosomatid culture collection 
of the Department of Entomology, Tropical Medicine Foundation 
of Amazonas.
To genotype the isolated parasites, total DNA extraction from 
in vitro isolates of T. cruzi was performed using the PureLink 
Kit (Invitrogen, Life Technologies, USA), according to the 
manufacturer’s protocol. DNA was prepared from 200µL of culture 
and eluted with 50µL of milliQ water. DNA from the non-transcribed 
spacer of the mini-exon was amplified according to the protocol 
reported by Fernandes et al.9 The T. cruzi isolates were typed as 
TcI or Z3 lineages (Monteiro et al., in preparation).
Inoculation of mice 
Groups of 7 male Swiss mice (age, 12-15 days) originating 
from the vivarium of the Department of Venomous Animals, 
Tropical Medicine Foundation of Amazonas, were inoculated 
intraperitoneally with 1.0 × 106 metacyclic trypomastigotes from 
a late-stationary-phase culture in liver-infusion tryptose medium, 
determined in a Neubauer chamber. The mice were maintained in 
large boxes in a well-ventilated room, with ad libitum access to a 
commercial pellet feed for rodents and drinking water.
Parasitological parameters
Fresh blood examination: we collected 5 µL of blood daily from 
the tails of the mice and examined it microscopically for living 
trypomastigotes. The level of parasitemia was measured daily from 
the 3rd day after inoculation, as described by Brener10. The results 
were also expressed as the percentage of mice with positive fresh 
blood examination results (FBE; %+FBE). The pre-patent period 
(PPP), patent period (PP), maximum parasitemia (MP), and the 
day of maximum parasitemia (DMP) were determined, according 
to the protocol reported by Toledo et al.11 
Hemoculture: At 90 days after inoculation (d.a.i.), a blood sample 
collected by cardiac puncture was cultured as described above, in 
duplicate. The hemocultures (HCs) were maintained at 28°C and 
examined at 15, 30, 60, and 90 days later for parasites. The results were 
expressed as the percentage of mice with a positive HC (%+HC)11.
Infectivity and mortality
Infectivity (%INF) was determined as the percentage of mice 
that presented with a positive FBE and/or HC in the first 3 months 
after inoculation11. 
Mortality (%MOR) was registered daily after inoculation and 
expressed as the cumulative percentage of death.
Histopathological parameters
For each T. cruzi stock, all surviving mice were necropsied at 
90 d.a.i. for histopathological studies. The following organs and 
tissues were collected: (1) heart, (2) skeletal muscle, (3) lungs, (4) 
large intestine, (5) brain, (6) liver, and (7) spleen. This material was 
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TABLE 2 - Parasitological and virulence parameters in Swiss mice inoculated with Trypanosoma cruzi stocks from the State of 
Amazonas, Brazil.
 Mean pre- Mean patent Peak of Day of    
 patent period  period   maximum   maximum     
Trypanosoma cruzi stock  (days) (days) parasitemia* parasitemia %+FBE %+HC %INF %MOR
AM28 - 0 0 0 0/7 (0.0) 5/5 (100.0) 100.0 2/7 (28.6)
AM38 78 1 1,400 78 1/7 (14.3) 7/7 (100.0) 100.0 0/7 (0.0)
AM41 - 0 0 0 0/7 (0.0) 0/6 (0.0) 0.0 1/7 (14.3)
AM49 74 1 1,400 74 1/7 (14.3) 5/6 (83.3) 83.3 1/7 (14.3)
AM61 23 15 2,800 35 2/7 (28.6) 2/2 (100.0) 100.0 5/7 (71.4)
AM69 - 0 0 0 0/7 (0.0) 0/6 (0.0) 0.0 1/7 (14.3)
AM70 - 0 0 0 0/7 (0.0) 0/7 (0.0) 0.0 0/7 (0.0)
%+FBE: percentage of mice with a positive fresh blood examination; %+HC: percentage of positive hemocultures for surviving mice; 
%INF: infectivity rate; %MOR: cumulative mortality rate. *number of trypomastigotes/0.1 mL blood.
TABLE 3 - Statistical comparison of 8 parasitological parameters in Swiss mice inoculated with Trypanosoma cruzi 
stocks from different hosts in the State of Amazonas, Brazil.
 Humans × triatomines Humans × marsupials Triatomines × marsupials
Parameter nH × nT p nH × nM p nT × nM p
Mean pre-patent period (days)* 74 × 23 <0.001 74 × 78 <0.001 23 × 78 <0.001
Mean patent period (days) 0.33 × 7.5 <0.001 0.33 × 0.5 NS 7.5 × 0.5 0.002
Peak of maximum parasitemia** 466.7 × 1,400 0.015 466.7 × 700 NS 1,400 × 700 NS
Day of maximum parasitemia 24.7 × 17.5 NS 24.7 × 39 NS 17.5 × 39 NS
%+FBE 4.7 × 14.3 0.012 4.8 × 7.1 NS 14.3 × 7.1 0.012
%+HC 26.3 × 25 NS 26.3 × 100 <0.001 25 × 100 0.002
%INF 26.3 × 25 NS 26.3 × 100 <0.001 25 × 100 0.002
%MOR 9.5 × 42.9 0.021 9.5 × 14.3 NS 42.9 × 14.3 NS
Number of significant differences 5 3 5
nH × nT: comparison between parameters derived from humans and triatomines; nH × nM: comparison between parameters 
derived from humans and marsupials; nT × nM: comparison between parameters derived from triatomines and marsupials; 
%+FBE: percentage of mice with a positive fresh blood examination; %+HC: percentage of positive hemocultures for 
the surviving mice; %INF: infectivity rate; %MOR: cumulative mortality rate. p < 0.05: significant difference; NS: not 
significant. *only for stocks AM38, AM49, and AM61; **number of trypomastigotes/0.1mL blood.
routinely processed and embedded in paraffin. Five-micrometer 
sections of 3 blocks containing every organ of each mouse were 
obtained for further evaluation. These preparations were stained 
with hematoxylin-eosin for microscopic examination. The tissue 
parasitism (TP) and inflammatory process (IP) displayed by different 
organs or tissues were classified as absent (–), mild (+), moderate 
(++), and severe (+++).
Statistical analysis
Data were analyzed using SPSS® version 16.0 for Windows 
(SPSS Inc.®, Chicago, IL, USA). The chi-square test was used to 
test differences in proportions, and Student’s t test was used to test 
differences in means. Statistical significance was considered if p < 0.05.
Ethical considerations
The use of stocks of T. cruzi obtained from patients was approved 
by the Ethics in Research on Humans Committee of the Tropical 
Medicine Foundation of the State of Amazonas (approval no. 
360/07). The capture and handling of marsupials for blood sample 
collection were performed according to permits from the Brazilian 
Institute for Environment (approval no. 1830651/07). The use 
of mice in this study followed the ethical principles for animal 
experimentation12.
Four of the stocks evaluated (AM28, AM41, AM69, and AM70) 
did not lead to patent parasitemia. The parasitological parameters, 
infectivity, and mortality obtained from the isolates are shown in 
Table 2. Stock AM49 promoted intense lethargy, hind limb paralysis, 
and ruffled coat in mice. For stocks AM41, AM49, and AM69, death 
occurred at 68, 49, and 46  d.a.i., respectively. Death occurred at 
28 and 35 d.a.i. for stock AM28. One of the 7 stocks (AM61) caused 
a higher %MOR in mice (71.4%), and all deaths occurred on the 
17 d.a.i. This stock led to intense lethargy and ruffled coat in mice.
The stock isolated from the marsupial Philander opossum showed 
a significantly longer mean PPP than the stocks obtained from 
humans and triatomines (p < 0.001); for the stocks from humans, 
this parameter was significantly longer than that from triatomines 
(p < 0.001). The mean PP was longer for the stocks from triatomines 
(p < 0.005). These stocks led to an MP that was significantly higher 
than for the stocks derived from the others hosts (p = 0.015). The 
DMP did not differ significantly among stocks from the different 
hosts (Table 3).
Stocks obtained from Rhodnius robustus showed a significantly 
higher %+FBE than human- and marsupial-derived stocks 
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(p < 0.05). The parameters %+HC and %INF were higher for stocks 
from marsupials in relation to the others (p < 0.05). Stocks isolated 
from triatomines led to a higher %MOR than stocks from humans 
(p = 0.021) (Table 3).
Heart tissue parasitism was observed in 2 (28.6%) mice infected 
with stock AM49 (Figure 1) and in 1 (14.3%) mouse infected with 
stock AM61. Tissue parasitism was not verified in the other organs 
examined. All mice inoculated with stock AM49 showed focal and 
TABLE 4 - Histopathological parameters (tissue parasitism and inflammatory process) in mice 
inoculated with Trypanosoma cruzi stocks from the State of Amazonas, Brazil.
                                    Organ
  skeletal splee live lungs  large   
Trypanosoma cruzi stock heart muscle n  r   intestine brain
AM28 + ++ - - - - -
AM38 + ++ - - - - -
AM41 - - - - - - -
AM49 ++* +++ - - - - +
AM61 +* + - - - - -
AM69 + + - - - - -
AM70 - + - - - - -
+: mild; ++: moderate; +++: severe; -: absent; *only showing mild tissue parasitism.
moderate IP in heart tissue (Figure 1). Focal and mild IP was observed 
in the heart tissue of mice inoculated with stocks AM28, AM38, AM61, 
and AM69. The IP in skeletal muscle was diffuse and intense in mice 
inoculated with stock AM49, moderate with stocks AM28 and AM38, 
and mild with stocks AM61, AM69, and AM70 (Table 4). Examination 
of brain tissue revealed inflammatory foci and gliosis in 4 (57.1%) mice 
inoculated with stock AM49 (Figure 1). An IP was not observed in 
spleen, liver, lungs, or large intestine for any group of mice (Table 4).
FIGURE 1 - Histopathological alterations in Swiss mice triggered by stock AM49: A and B: nests of amastigotes in cardiac tissue. 
C: diffuse inflammatory process in skeletal muscle. D: inflammatory process and gliosis in the central nervous system. 
Magnification ×400.
In the State of Amazonas, chronic Chagas disease has lower 
morbidity than in classic endemic areas, appearing mainly in the 
latent form1,5. Chagasic infection was first reported in this state by 
Ferraroni et al.13, who examined 25 individuals who performed 
piassava fiber extraction in the municipality of Barcelos, and found 
6 individuals with positive serological test results. Cross-sectional 
assessments, including the clinical and radiological evaluations of 
anti-T. cruzi seropositive patients in the Rio Negro micro-region, 
ratified the high seroprevalence of chagasic infection in this region 
and showed a clinical profile of low morbidity and mortality in the 
chronic phase of the disease5–7. 
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Trypanosoma cruzi stocks have been characterized on the basis 
of their biological behavior in mice14,15. The present study with 
stocks from the State of Amazonas, a non-endemic but emerging 
area for Chagas disease, showed that 4 (AM28, AM41, AM69, and 
AM70) of the 7 stocks studied produced sub-patent parasitemia. 
Furthermore, the other 3 stocks that caused patent infections in mice 
produced low and late parasitemia, with peaks not exceeding 2,800 
trypomastigotes/0.1 mL blood. In relation to the parasitemia, we 
observed that this profile was very different from those observed in 
endemic areas, where stocks with variable parasitemia circulate, but 
with frequent rates of patent infections, in particular for stocks isolated 
from chronic patients14–18. In this study, low parasitemia, a very long 
PPP, and short PP indicate the low virulence of the strains from the 
western Amazon region. These findings agree with the hypothesis of 
several authors who suggested that the framework of chronic latent 
infection in the State of Amazonas is due to the low parasitemia and 
lower virulence and pathogenicity of the wild parasites in this area.
An important practical aspect that can be explained by the low 
parasitemia for the T. cruzi stocks isolated from the Amazon region is 
the low performance of the diagnostic methods for Chagas disease in 
this area. In Bolivia and in the classic Brazilian endemic areas, where 
the TcII genotype circulates and infections involve high levels of 
parasitemia, diagnostic tests are very sensitive, in contrast with areas 
from Amazonia and Mexico, where the TcI genotype occurs5,19–21. In 
the Brazilian Amazon and Venezuela, diagnostic tests employed in 
the acute phase of Chagas disease showed low sensitivity22–24. Brum-
Soares et al.5 also verified that chronic chagasic patients from the 
Rio Negro micro-region presented with low IgG anti-T. cruzi serum 
levels, probably due to the low parasite load and/or low antigenic 
power of the circulating parasites. Interestingly, our findings support 
the first suggestion.
Stocks AM41, AM69, and AM70 were unable to infect mice, both 
in FBE and HC, confirming the low virulence of these isolates. For 
stocks AM28, AM38, AM49, and AM61, we found high infectivity 
rates by HC, despite their low level of parasitemia. If this features 
is reproduced in human hosts, an important implication is the lack 
or delay in diagnosis of acute Chagas disease, since direct methods 
are being used and recommended in the Amazon region because 
this is the same approach used for the detection of malaria cases, 
which would make a parallel program control. These data support 
the findings of previous studies, which reported that sylvatic stocks 
from the United States, where the TcI and zymodeme 3 genotypes 
circulate, as in the Brazilian Amazon, were largely avirulent and did 
not cause morbidity or mortality in rodent models25. In contrast, 
T. cruzi stocks from the classic endemic areas of South America 
readily infect a wide variety of laboratory mouse strains and many 
cause significant morbidity and mortality12,16,26.
Stocks from marsupials (AM28 and AM38) infected all of the 
mice inoculated, although with low parasitemia. Previous mouse 
infection studies using several sylvatic- and domestic-derived isolates 
from Brazil showed that those from marsupials were generally more 
infective and generated higher parasitemia than those from vectors 
or placental mammals16,26. Stock AM61, which originated from a 
specimen of Rhodnius robustus collected in the municipality of Apuí, 
was the other infective isolate and the only one that promoted a 
high mortality rate, highlighting the southern Amazon region as an 
area in which the eco-epidemiology of Chagas disease needs to be 
studied further.
More sensitive methods, e.g., molecular detection by the 
polymerase chain reaction (PCR), may increase T. cruzi infectivity 
when applied to experimental studies in mice. Thus, we recognize 
this limitation, although a large number of studies have used the 
same methods for detecting infection, and stated that caution 
should be taken when these data are compared with other results. 
T. cruzi infection can be diagnosed by demonstrating the presence 
of the parasite using direct and indirect parasitological methods, 
immunodiagnosis to detect specific antibodies against T. cruzi, or 
by molecular methods for parasite DNA. The high rate of positivity 
using PCR suggested this methodology as a diagnostic tool for the 
detection of T. cruzi DNA in the blood of different host species27. 
Although the majority of the sylvatic and human stocks isolated 
from the western Amazon were largely non-virulent and did not cause 
morbidity or mortality in our model, we noted an interesting result in 
an experimental infection with stock AM49. This strain was isolated 
from the cerebrospinal fluid of an infant misdiagnosed primarily as 
skin abscesses, which evolved to a fatal outcome due to acute Chagas 
disease meningoencephalitis (unpublished information), and was the 
only isolate from patients that was able to infect mice. The group of 
mice infected with this isolate showed relatively low mortality and 
parasitemia, despite its high infectivity and frequency of observable 
physical or behavioral changes indicative of Chagas disease, e.g., 
lethargy, hind limb paralysis, and ruffled coat. Histopathological 
alterations triggered by this stock included an intense IP of skeletal 
muscles, moderate inflammation and parasitism in the heart, and, 
surprisingly, inflammation and gliosis in the brain of the infected 
mice. These results suggest that this stock could belong to biodeme 
III3, with a dissimilar neurotropic behavior.
Inflamatory process or tissue parasitism was not observed in the 
liver or spleen of the infected mice; however, even in animals with no 
evident parasitemia, IP was observed in skeletal muscle tissue and, 
less frequently, in cardiac tissue. In addition, 2 stocks also promoted 
tissue parasitism in rodents, indicating that some stocks of T. cruzi 
from the State of Amazonas can behave like biodeme III parasites3. 
In fact, infrequent chronic cardiac cases of Chagas disease confirm 
that parasites circulating in this area cause myocardiopathy, appearing 
clinically as cardiac insufficiency, arrhythmogenic syndrome, or 
thromboembolism28–33. The absence of histopathological alterations 
in the large intestine indicates that the parasites studied did not have 
the capacity to cause digestive Chagas disease, in agreement with the 
absence of records of mega syndromes in Amazonian countries and 
Central and North America34.
In conclusion, our data suggest that the biological characteristics 
of T. cruzi stocks from the western Amazon region may vary 
considerably. The disproportion between the number of cases 
of infection and clinical disease in this region may result from 
the predominance of non-virulent strains. However, our study 
demonstrated the occurrence of stocks that can cause cardiac and 
nervous involvement. Therefore, we recommend the biological 
characterization of a great number of stocks to define the real 
potential for the emergence of Chagas disease as a public health 
problem in the Amazonian context.
The belief that Chagas disease may be benign in some geographic 
areas, as in the Amazon region, derives from misinformation or lack 
of more thorough investigations. Under no circumstances should it 
serve to postpone control measures once the risk of transmission to 
humans has been established.
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